Herbalife Results Don’t Crown a Winner

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Nutrition Supplement
Thinkstock
Someone’s going to take a beating after today’s earnings results from Herbalife Ltd. (NYSE: HLF). Will it be Carl Icahn, who now owns about 13% of the company’s stock, or will it be William Ackman, who stands on a huge short position in the shares?

Herbalife Ltd. (NYSE: HLF) reported fourth-quarter and full-year 2012 results after the markets closed today. Quarterly diluted earnings per share (EPS) were $1.05 on revenues of $1.06 billion. In the same period a year ago, the nutrition and weight-loss company reported EPS of $0.86 on revenues of $884.57 million. The Thomson Reuters estimates called for EPS of $1.03 and $1.05 billion in revenue.

For the full year, Herbalife posted EPS of $4.05 on revenues of $4.07 billion, compared with 2011 EPS of $3.30 on revenues of $3.45 billion. The consensus estimates called for EPS of $4.04 on revenues of $4.07 billion.

The company’s CEO said:

Herbalife continues to deliver record results in sales and profitability as our independent distributors go deeper into existing markets, developing more and more customers using our nutrition products every day

But does anyone really care how the company actually performed during the quarter and for the past year? Probably not. Sure Herbalife beat its quarterly estimates and even squeaked out an EPS beat for the year on inline revenues. So, what does that mean for Icahn and Ackman?

The results are not a bone-crushing victory or defeat for either side. Ackman will probably get the worst of it when trading begins tomorrow, but his interest is not in Herbalife’s numbers, which he claims are the result of a pyramid scheme anyway. The silver lining for Ackman is that Herbalife’s results could possibly be used to put more pressure on the federal government to open an investigation against Herbalife.

But an inquiry probably won’t happen on the basis of these results. They’re just not exciting enough. As for Icahn, he can wait a bit or urge Herbalife to spread some of its cash around to shareholders. Any bets on which course he’ll choose?

Herbalife shares closed at $39.74 today against a prior 52-week trading range of $24.24 to $73.00. Shares have risen about 2.5% to $40.75 in after-hours trading. Thomson Reuters had a consensus analyst price target of around $63.10 before today’s report.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618